NCT00330993View on ClinicalTrials.gov

Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

March 31, 2006

Study Completion Date

August 31, 2006

Conditions

Abortion, Induced

Interventions

DRUG

mifepristone, misoprostol

Trial Locations (1)

15213

Office of Family Planning Research, Magee-Womens Hospital, Pittsburgh

All Listed Sponsors

lead

University of Pittsburgh

OTHER

NCT00330993 - Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation | Biotech Hunter | Biotech Hunter